Fischer Medical Ventures Board of Directors

Get the latest insights into the leadership at Fischer Medical Ventures. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Ravindran Govindan Chairman & Managing Director
Ms. Svetlana Rao Whole Time Executive Director
Mr. Sanjay Jayantilal Jain Independent Director
Mr. Jaya Ankur Singhania Independent Director
Mr. Khairy Jamaluddin Abu Bakkar Independent Director
Mr. Roberto M Pagdanganan Independent Director

Fischer Medical Ventures Share price

FISCHER

96.54

2.55 (2.71%)
NSE
BSE
Last updated on 6 Nov, 2025 | 15:41 IST
BUYSELL
Today's High

99.00

Today's Low

93.90

52 Week Low

77.01

52 Week High

124.70

The current prices are delayed, login to your account for live prices

Fischer Medical Ventures FAQs

The board at Fischer Medical Ventures consists of experienced professionals, including Mr. Ravindran Govindan , Ms. Svetlana Rao , and others, overseeing the company’s strategic and corporate governance.

Directors at Fischer Medical Ventures are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Ravindran Govindan is the current chairman at Fischer Medical Ventures.

Executive directors at Fischer Medical Ventures are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Fischer Medical Ventures adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Fischer Medical Ventures, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.